CAN
CRL icon

Claraphi Advisory Network’s Charles River Laboratories CRL Stock Holding History

Claraphi Advisory Network’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-708
Closed -$292K – 299
2021
Q3 		$292K Buy
+708
New +$294K 0.1% 220
2020
Q3 		– Sell
-1,163
Closed -$203K – 260
2020
Q2 		$203K Buy
1,163
+9
+0.8% +$1.44K 0.09% 239
2020
Q1 		$146K Buy
+1,154
New +$173K 0.07% 254
2019
Q2 		– Sell
-1,432
Closed -$208K – 244
2019
Q1 		$208K Buy
+1,432
New +$188K 0.13% 205
2018
Q4 		– Sell
-1,943
Closed -$262K – 219
2018
Q3 		$262K Buy
1,943
+115
+6% +$14.2K 0.15% 194
2018
Q2 		$206K Buy
+1,828
New +$198K 0.13% 232

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return